Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Marian Nakada
VP VENTURE INVESTMENTS, JOHNSON & JOHNSON
In today’s disruptive health care environment, how will biotech transform?
Wassim Nashabeh, PhD
VICE PRESIDENT, REGULATORY POLICY & INTERNATIONAL OPERATIONS, GENENTECH, A MEMBER OF THE ROCHE GROUP
The Road to Global Alignment: A Discussion on International Regulatory Harmonization
Imran Nasrullah, MS, JD
VICE PRESIDENT & HEAD, COLLABORATE TO CURE HUB US,BD&L, BAYER PHARMACEUTICALS, BAYER
Life Sciences Ecosystems: Evolving Growth Patterns for Successful Incubation
Alexander Natz
SECRETARY GENERAL, EUCOPE
The New European Pharmaceutical Landscape: What You Need to Know When Launching in the EU
Lila Neel
NATIONAL DIRECTOR, PROJECT ONRAMP, LIFE SCIENCE CARES
Student Day Welcome & Session
Placeholder Photo
Ed Neilan
CHIEF MEDICAL OFFICER, NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD)
Accelerated Approval Under Pressure: What’s At Stake and What Can Be Done?
Edward Neilan, PhD,MD
CHIEF MEDICAL AND SCIENTIFIC OFFICER, NATIONAL ORGANIZATION FOR RARE DISORDERS
The Future of Non-Viral Gene Therapy: Accelerating Next-Generation Gene Therapies
Quincy, Massachusetts, United States
Gina Nellesen
INTELLECTUAL PROPERTY COUNSEL, BEIGENE USA, INC.
Theoretical Patent Thickets v. Data-Driven Patent Policy: Are Changes Necessary at the PTO & FDA?
Frank Nestle, MD
GLOBAL HEAD OF RESEARCH AND CHIEF SCIENTIFIC OFFICER, SANOFI
Fireside Chat with Frank Nestle, Global Head of Research and CSO, Sanofi
Paul Neureiter
EXECUTIVE DIRECTOR, INTERNATIONAL POLICY, AMGEN
Thou Shalt Not Pass? How to Navigate the Latest Policies on Cross-Border Data Flow